Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Guwei Huoluo Tincture (古威活络酊) is a traditional Chinese medicine (TCM) topical solution developed and manufactured by Guizhou Shengshilongfang Pharmaceutical. Formulated as an external tincture, it is indicated for the treatment of musculoskeletal conditions, including rheumatism, joint pain, waist and knee aches, and traumatic injuries. The preparation is designed to expel wind and dampness, relax tendons, activate collaterals, and reduce swelling and pain through the synergistic action of its herbal constituents. It is an approved pharmaceutical product in China (Approval No. 国药准字Z20025071), typically applied topically to the affected area to promote local blood circulation and alleviate inflammatory symptoms associated with arthritis and soft tissue damage.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Guwei Huoluo Tincture.